Long-Term Spontaneous Control of HIV-1 Is Related to Low Frequency of Infected Cells and Inefficient Viral Reactivation

ABSTRACT HIV establishes reservoirs of infected cells that persist despite effective antiretroviral therapy (ART). In most patients, the virus begins to replicate soon after treatment interruption. However, a low frequency of infected cells at the time of treatment interruption has been associated with delayed viral rebound. Likewise, individuals who control the infection spontaneously, so-called HIV-1 controllers (HICs), carry particularly low levels of infected cells. It is unclear, however, whether and how this small number of infected cells contributes to durable viral control. Here we compared 38 HICs with 12 patients on effective combined antiretroviral therapy (cART) and found that the low frequency of infected cells in the former subjects was associated both with less efficient viral reactivation in resting CD4+ T cells and with less efficient virion production ex vivo. We also found that a potent HIV-specific CD8+ T cell response was present only in those HICs whose CD4+ T cells produced virus ex vivo. Long-term spontaneous control of HIV infection in HICs thus appears to be sustained on the basis of the inefficient reactivation of viruses from a limited number of infected cells and the capacity of HICs to activate a potent HIV-specific CD8+ T cell response to counteract efficient viral reactivation events. IMPORTANCE There is a strong scientific interest in developing strategies to eradicate the HIV-1 reservoir. Very rare HIV-1-infected patients are able to spontaneously control viremia for long periods of time (HIV-1 controllers [HICs]) and are put forward as a model of HIV-1 remission. Here, we show that the low viral reservoirs found in HICs are a critical part of the mechanisms underlying viral control and result in a lower probability of HIV-1 reactivation events, resulting in limited HIV-1 release and spread. We found that those HICs in whom viral reactivation and spread from CD4+ T cells in vitro were the most difficult were those with diminished CD8+ T cell responses. These results suggest that, in some settings, low HIV-1 reservoirs decisively contribute to at least the temporary control of infection without antiretroviral therapy. We believe that this work provides information of relevance in the context of the search for HIV-1 remission.

[1]  M. Lichterfeld,et al.  Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth , 2016, PLoS pathogens.

[2]  C. Rouzioux,et al.  A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control , 2015, AIDS.

[3]  F. Pereyra,et al.  The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers , 2015, Journal of Virology.

[4]  Arsène Burny,et al.  An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression , 2015, PLoS pathogens.

[5]  Richard D Moore,et al.  Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection. , 2014, The Journal of infectious diseases.

[6]  Daniel I. S. Rosenbloom,et al.  Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations. , 2015, The Journal of clinical investigation.

[7]  B. Malleret,et al.  Long-Term Control of Simian Immunodeficiency Virus (SIV) in Cynomolgus Macaques Not Associated with Efficient SIV-Specific CD8+ T-Cell Responses , 2015, Journal of Virology.

[8]  Richard D Moore,et al.  Elite Controllers are Hospitalized More Often than Persons with Medically Controlled HIV , 2014 .

[9]  Correction for Hill et al., Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1 , 2014, Proceedings of the National Academy of Sciences.

[10]  Emily B Hanhauser,et al.  Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell Transplantation , 2014, Annals of Internal Medicine.

[11]  F. Pereyra,et al.  A cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4(+) T cells from elite controllers. , 2014, Cell host & microbe.

[12]  Feng Fu,et al.  Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1 , 2014, Proceedings of the National Academy of Sciences.

[13]  A. De Maria,et al.  Absence of HIV-1 after treatment cessation in an infant. , 2014, The New England journal of medicine.

[14]  R. Kaul,et al.  Effect of antiretroviral therapy on HIV reservoirs in elite controllers. , 2013, The Journal of infectious diseases.

[15]  Sarah B. Laskey,et al.  Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.

[16]  C. Rouzioux,et al.  Both HLA-B*57 and Plasma HIV RNA Levels Contribute to the HIV-Specific CD8+ T Cell Response in HIV Controllers , 2013, Journal of Virology.

[17]  Jeffrey N. Martin,et al.  Prospective Antiretroviral Treatment of Asymptomatic, HIV-1 Infected Controllers , 2013, PLoS pathogens.

[18]  A. Sáez-Cirión,et al.  HIV controllers: a genetically determined or inducible phenotype? , 2013, Immunological reviews.

[19]  Brigitte Autran,et al.  Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study , 2013, PLoS pathogens.

[20]  C. Rouzioux,et al.  Hiv-1 Control after Transient Antiretroviral Treatment Initiated in Primary Infection: Role of Patient Characteristics and Effect of Therapy , 2012, Antiviral therapy.

[21]  J. Gatot,et al.  Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients , 2012, AIDS.

[22]  F. Pereyra,et al.  Elite Controllers with Low to Absent Effector CD8+ T Cell Responses Maintain Highly Functional, Broadly Directed Central Memory Responses , 2012, Journal of Virology.

[23]  R. Paredes,et al.  In–Depth Characterization of Viral Isolates from Plasma and Cells Compared with Plasma Circulating Quasispecies in Early HIV-1 Infection , 2012, PloS one.

[24]  R. Siliciano,et al.  Host Factors Dictate Control of Viral Replication in two HIV-1 Controller/Chronic Progressor Transmission Pairs , 2012, Nature Communications.

[25]  A. Bergamaschi,et al.  Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers. , 2011, Blood.

[26]  S. Lewin,et al.  HIV cure and eradication: how will we get from the laboratory to effective clinical trials? , 2011, AIDS.

[27]  C. Rouzioux,et al.  CD4 Dynamics over a 15 Year-Period among HIV Controllers Enrolled in the ANRS French Observatory , 2011, PloS one.

[28]  E. Rosenberg,et al.  CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. , 2011, The Journal of clinical investigation.

[29]  Jack T Stapleton,et al.  The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation , 2010, Science.

[30]  Thierry Prazuck,et al.  Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection , 2010, AIDS.

[31]  C. Mussini,et al.  Predictive value of intracellular HIV-1 DNA levels during CD4-guided treatment interruption in HIV+ patients. , 2010, AIDS research and human retroviruses.

[32]  A. Sáez-Cirión,et al.  Ex vivo T cell–based HIV suppression assay to evaluate HIV-specific CD8+ T-cell responses , 2010, Nature Protocols.

[33]  R. Siliciano,et al.  Control of HIV-1 in Elite Suppressors despite Ongoing Replication and Evolution in Plasma Virus , 2010, Journal of Virology.

[34]  M. Carrington,et al.  Enhanced Anti-HIV Functional Activity Associated with Gag-Specific CD8 T-Cell Responses , 2010, Journal of Virology.

[35]  B. Walker,et al.  Replicative Capacity of Human Immunodeficiency Virus Type 1 Transmitted from Mother to Child Is Associated with Pediatric Disease Progression Rate , 2009, Journal of Virology.

[36]  Arsène Burny,et al.  Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection , 2009, PloS one.

[37]  C. Rouzioux,et al.  Heterogeneity in HIV Suppression by CD8 T Cells from HIV Controllers: Association with Gag-Specific CD8 T Cell Responses1 , 2009, The Journal of Immunology.

[38]  E. Verdin,et al.  Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation , 2009, PLoS pathogens.

[39]  Amy S. Espeseth,et al.  Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. , 2009, AIDS research and human retroviruses.

[40]  Avettand‐Fènoël Véronique,et al.  LTR real‐time PCR for HIV‐1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01) , 2009 .

[41]  C. Rouzioux,et al.  LTR Real-Time PCR for HIV-1 DNA Quantitation in Blood Cells for Early Diagnosis in Infants Born to Seropositive Mothers Treated in HAART Area ( ANRS CO 01 ) , 2008 .

[42]  C. Rouzioux,et al.  HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors , 2008, AIDS.

[43]  Todd M. Allen,et al.  Genetic Characterization of Human Immunodeficiency Virus Type 1 in Elite Controllers: Lack of Gross Genetic Defects or Common Amino Acid Changes , 2008, Journal of Virology.

[44]  Terri Wrin,et al.  Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. , 2008, The Journal of infectious diseases.

[45]  Tina Lenasi,et al.  HMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription , 2007, PLoS pathogens.

[46]  M. Peeters,et al.  Impact of HIV-1 Genetic Diversity on Plasma HIV-1 RNA Quantification: Usefulness of the Agence Nationale de Recherches sur le SIDA Second-Generation Long Terminal Repeat-Based Real-Time Reverse Transcriptase Polymerase Chain Reaction Test , 2007, Journal of acquired immune deficiency syndromes.

[47]  C. Rouzioux,et al.  Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study) , 2007, AIDS.

[48]  Asier Sáez-Cirión,et al.  HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype , 2007, Proceedings of the National Academy of Sciences.

[49]  E. Rosenberg,et al.  Fully Differentiated HIV-1 Specific CD8+ T Effector Cells Are More Frequently Detectable in Controlled than in Progressive HIV-1 Infection , 2007, PloS one.

[50]  R. Siliciano,et al.  Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors , 2006, Journal of Virology.

[51]  Mario Roederer,et al.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.

[52]  P. Morlat,et al.  CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patients. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  C. Rouzioux,et al.  Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. , 2005, The Journal of infectious diseases.

[54]  W. Greene,et al.  Prostratin Antagonizes HIV Latency by Activating NF-κB* , 2004, Journal of Biological Chemistry.

[55]  T. Perneger,et al.  Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions , 2004, AIDS.

[56]  W. Greene,et al.  Prostratin antagonizes HIV latency by activating NF-kappaB. , 2004, The Journal of biological chemistry.

[57]  K. Shuai,et al.  Regulation of JAK–STAT signalling in the immune system , 2003, Nature Reviews Immunology.

[58]  C. Hallahan,et al.  HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors , 2002, Nature Immunology.

[59]  E. Rosenberg,et al.  Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[60]  F. Marincola,et al.  HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.